BioCentury | Feb 17, 2017
Clinical News

HOST-G904: Proof-of-concept trial data

...at day 21 were associated with lower volumes of gas-related symptoms. Data were published in Alimentary...
BioCentury | Apr 20, 2015
Company News

J&J, University College Cork deal

...The university’s Alimentary Pharmabiotic Center’s Microbiome Institute partnered with the pharma’s Janssen Biotech Inc. unit to...
BioCentury | Apr 16, 2015
Finance

Public-Private Partnership Roundup

...developing biology about the microbiome with a new collaboration between its Janssen unit and the Alimentary...
BioCentury | Jul 10, 2014
Financial News

Luye raises $509.8 million in Hong Kong IPO

...Chinese medicine (TCM) primarily in China. The company's pipeline includes products in oncology, cardiovascular and alimentary...
BioCentury | Jun 27, 2014
Financial News

Luye files for Hong Kong IPO

...Chinese medicine (TCM) primarily in China. The company's pipeline includes products in oncology, cardiovascular and alimentary...
BioCentury | May 27, 2013
Emerging Company Profile

Calypso: Fistula fix

...of action is mostly anti-inflammatory and not anti-fibrotic, according to Vicari. A study published in Alimentary...
BioCentury | Oct 29, 2012
Finance

Fosun's Foreign Foray

...traded on the Shanghai Stock Exchange since 1998 and manufactures 625 drugs for metabolic and alimentary...
BioCentury | Sep 5, 2011
Company News

Alimentary, Norgine deal

...The companies partnered to evaluate Alimentary's probiotic technology for the development of therapeutics to manage and...
...Alimentary will receive an upfront payment and is eligible for milestones. Details were not disclosed. Alimentary Health Ltd....
BioCentury | Sep 13, 2010
Clinical News

Apriso granulated mesalamine: Phase III data

...for mucosal appearance from baseline to 6 months vs. placebo (p=0.098). Data were published in Alimentary...
BioCentury | May 6, 2010
Targets & Mechanisms

Addressing a difficile problem

...with narrow-spectrum antimicrobial activity against Clostridium difficile . 1 The peptide, which is licensed to Alimentary Health Ltd....
...can delay this process," noted Colin Hill, a professor of microbial food safety in the Alimentary...
...R. Paul Ross, head of food research at Teagasc and a principal investigator at UCC's Alimentary...
Items per page:
1 - 10 of 22
BioCentury | Feb 17, 2017
Clinical News

HOST-G904: Proof-of-concept trial data

...at day 21 were associated with lower volumes of gas-related symptoms. Data were published in Alimentary...
BioCentury | Apr 20, 2015
Company News

J&J, University College Cork deal

...The university’s Alimentary Pharmabiotic Center’s Microbiome Institute partnered with the pharma’s Janssen Biotech Inc. unit to...
BioCentury | Apr 16, 2015
Finance

Public-Private Partnership Roundup

...developing biology about the microbiome with a new collaboration between its Janssen unit and the Alimentary...
BioCentury | Jul 10, 2014
Financial News

Luye raises $509.8 million in Hong Kong IPO

...Chinese medicine (TCM) primarily in China. The company's pipeline includes products in oncology, cardiovascular and alimentary...
BioCentury | Jun 27, 2014
Financial News

Luye files for Hong Kong IPO

...Chinese medicine (TCM) primarily in China. The company's pipeline includes products in oncology, cardiovascular and alimentary...
BioCentury | May 27, 2013
Emerging Company Profile

Calypso: Fistula fix

...of action is mostly anti-inflammatory and not anti-fibrotic, according to Vicari. A study published in Alimentary...
BioCentury | Oct 29, 2012
Finance

Fosun's Foreign Foray

...traded on the Shanghai Stock Exchange since 1998 and manufactures 625 drugs for metabolic and alimentary...
BioCentury | Sep 5, 2011
Company News

Alimentary, Norgine deal

...The companies partnered to evaluate Alimentary's probiotic technology for the development of therapeutics to manage and...
...Alimentary will receive an upfront payment and is eligible for milestones. Details were not disclosed. Alimentary Health Ltd....
BioCentury | Sep 13, 2010
Clinical News

Apriso granulated mesalamine: Phase III data

...for mucosal appearance from baseline to 6 months vs. placebo (p=0.098). Data were published in Alimentary...
BioCentury | May 6, 2010
Targets & Mechanisms

Addressing a difficile problem

...with narrow-spectrum antimicrobial activity against Clostridium difficile . 1 The peptide, which is licensed to Alimentary Health Ltd....
...can delay this process," noted Colin Hill, a professor of microbial food safety in the Alimentary...
...R. Paul Ross, head of food research at Teagasc and a principal investigator at UCC's Alimentary...
Items per page:
1 - 10 of 22